| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| FOXOFOXO Technologies Inc. | 175.02K | 0.00 | -0.00 | 26.89% | -66.46% | -48.71% | 2.70 | |
| HCTIHealthcare Triangle, Inc. | 3.27M | 0.45 | -0.00 | -64.77% | -48.85% | -72.45% | ||
| BFRGWBullfrog AI Holdings, Inc. Warrants | 2.05M | 0.20 | -0.23 | -100% | -57.71% | -346.39% | ||
| BFRGBullfrog AI Holdings, Inc. Common Stock | 8.66M | 0.76 | -0.89 | -100% | -57.71% | -346.39% |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Sales/Revenue | 28.74M | 31.34M | 35.27M | 45.89M | 33.2M | 11.7M |
| Revenue Growth % | - | 0.09% | 0.13% | 0.3% | -0.28% | -0.65% |
| Cost of Goods Sold | 22.89M | 22.75M | 24.75M | 34.59M | 26.43M | 8.81M |
| COGS % of Revenue | 0.8% | 0.73% | 0.7% | 0.75% | 0.8% | 0.75% |
| Gross Profit | 5.85M | 8.59M | 10.52M | 11.29M | 6.78M | 2.89M |
| Gross Margin % | 0.2% | 0.27% | 0.3% | 0.25% | 0.2% | 0.25% |
| Gross Profit Growth % | - | 0.47% | 0.23% | 0.07% | -0.4% | -0.57% |
| Operating Expenses | 4.18M | 7.41M | 15.88M | 21.71M | 18.13M | 7.64M |
| OpEx % of Revenue | 0.15% | 0.24% | 0.45% | 0.47% | 0.55% | 0.65% |
| Selling, General & Admin | 2.39M | 4.86M | 9.2M | 12.38M | 10.09M | 6.15M |
| SG&A % of Revenue | 0.08% | 0.16% | 0.26% | 0.27% | 0.3% | 0.53% |
| Research & Development | 1.01M | 1.74M | 5.26M | 5.95M | 799K | 429K |
| R&D % of Revenue | 0.04% | 0.06% | 0.15% | 0.13% | 0.02% | 0.04% |
| Other Operating Expenses | 776.13K | 803.19K | 1.42M | 3.37M | 7.23M | 1.06M |
| Operating Income | 1.67M | 1.18M | -5.36M | -10.42M | -11.35M | -4.75M |
| Operating Margin % | 0.06% | 0.04% | -0.15% | -0.23% | -0.34% | -0.41% |
| Operating Income Growth % | - | -0.29% | -5.55% | -0.94% | -0.09% | 0.58% |
| EBITDA | 2.45M | 1.98M | -3.94M | -7.04M | -4.12M | -3.86M |
| EBITDA Margin % | 0.09% | 0.06% | -0.11% | -0.15% | -0.12% | -0.33% |
| EBITDA Growth % | - | -0.19% | -2.99% | -0.79% | 0.42% | 0.06% |
| D&A (Non-Cash Add-back) | 776.13K | 803.19K | 1.42M | 3.37M | 7.23M | 889K |
| EBIT | 1.67M | 1.18M | -5.36M | -9.34M | -11.34M | -4.74M |
| Net Interest Income | -52.58K | -78.65K | -567K | -212K | -968K | -1.21M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 52.58K | 78.65K | 567K | 212K | 968K | 1.21M |
| Other Income/Expense | -52.58K | 1.43M | -565.95K | 869K | -956K | -1.21M |
| Pretax Income | 1.62M | 2.61M | -5.92M | -9.55M | -12.3M | -5.96M |
| Pretax Margin % | 0.06% | 0.08% | -0.17% | -0.21% | -0.37% | -0.51% |
| Income Tax | 444.37K | 257.38K | 24K | 63K | 35K | 12K |
| Effective Tax Rate % | 0.73% | 0.9% | 1% | 1.01% | 1% | 1% |
| Net Income | 1.17M | 2.35M | -5.95M | -9.61M | -12.34M | -5.97M |
| Net Margin % | 0.04% | 0.08% | -0.17% | -0.21% | -0.37% | -0.51% |
| Net Income Growth % | - | 1.01% | -3.53% | -0.62% | -0.28% | 0.52% |
| Net Income (Continuing) | 1.17M | 2.35M | -5.95M | -9.61M | -12.34M | -5.97M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 82.94 | 166.56 | -503.45 | -966.64 | -517.53 | -281.58 |
| EPS Growth % | - | 1.01% | -4.02% | -0.92% | 0.46% | 0.46% |
| EPS (Basic) | 82.94 | 166.56 | -503.45 | -966.64 | -517.53 | -281.58 |
| Diluted Shares Outstanding | 14.13K | 14.13K | 11.82K | 14.85K | 16.78K | 21.2K |
| Basic Shares Outstanding | 14.13K | 14.13K | 11.82K | 14.85K | 16.78K | 21.2K |
| Dividend Payout Ratio | - | - | - | - | - | - |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Total Current Assets | 5.29M | 8.03M | 11.8M | 7.75M | 5.73M | 1.45M |
| Cash & Short-Term Investments | 974.83K | 1.4M | 1.77M | 1.34M | 1.23M | 20K |
| Cash Only | 974.83K | 1.4M | 1.77M | 1.34M | 1.23M | 20K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 4.17M | 6.4M | 9.67M | 5.59M | 3.24M | 1.11M |
| Days Sales Outstanding | 52.97 | 74.5 | 100.1 | 44.48 | 35.57 | 34.64 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - |
| Other Current Assets | 146.3K | 228.85K | 361.48K | 816K | 1.26M | 322K |
| Total Non-Current Assets | 2.96M | 3.08M | 12.81M | 13.01M | 4.32M | 509K |
| Property, Plant & Equipment | 41.65K | 15.79K | 246.32K | 80K | 44K | 12K |
| Fixed Asset Turnover | 690.02x | 1985.24x | 143.19x | 573.58x | 754.61x | 974.67x |
| Goodwill | 0 | 0 | 1.29M | 1.29M | 0 | 0 |
| Intangible Assets | 2.92M | 2.62M | 10.46M | 10.57M | 3.97M | 0 |
| Long-Term Investments | 0 | 445K | 816.24K | 1.07M | 304K | 497K |
| Other Non-Current Assets | 0 | 445K | 816.24K | 1.07M | 0 | 0 |
| Total Assets | 8.25M | 11.11M | 24.61M | 20.76M | 10.05M | 1.96M |
| Asset Turnover | 3.48x | 2.82x | 1.43x | 2.21x | 3.30x | 5.96x |
| Asset Growth % | - | 0.35% | 1.22% | -0.16% | -0.52% | -0.8% |
| Total Current Liabilities | 6.2M | 6.78M | 6.25M | 6.15M | 8.12M | 7.08M |
| Accounts Payable | 5.1M | 4.35M | 1.87M | 1.48M | 1.95M | 2.54M |
| Days Payables Outstanding | 81.33 | 69.78 | 27.62 | 15.63 | 26.98 | 105.24 |
| Short-Term Debt | 0 | 754.4K | 3.28M | 2.41M | 3.43M | 2.65M |
| Deferred Revenue (Current) | 749.03K | 297.77K | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 349.14K | 1.38M | 923.88K | 2.25M | 2.74M | 1.89M |
| Current Ratio | 0.85x | 1.18x | 1.89x | 1.26x | 0.71x | 0.21x |
| Quick Ratio | 0.85x | 1.18x | 1.89x | 1.26x | 0.71x | 0.21x |
| Cash Conversion Cycle | - | - | - | - | - | - |
| Total Non-Current Liabilities | 79.04K | 0 | 2.23M | 2.23M | 1.39M | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 888K | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 79.04K | 0 | 2.23M | 2.23M | 500K | 0 |
| Total Liabilities | 6.28M | 6.78M | 8.48M | 8.38M | 9.51M | 7.08M |
| Total Debt | 0 | 754.4K | 3.45M | 2.41M | 4.32M | 2.65M |
| Net Debt | -974.83K | -648.3K | 1.68M | 1.07M | 3.08M | 2.63M |
| Debt / Equity | - | 0.17x | 0.21x | 0.19x | 8.02x | - |
| Debt / EBITDA | - | 0.38x | - | - | - | - |
| Net Debt / EBITDA | -0.40x | -0.33x | - | - | - | - |
| Interest Coverage | 31.75x | 14.96x | -9.45x | -49.13x | -11.72x | -3.92x |
| Total Equity | 1.97M | 4.33M | 16.13M | 12.39M | 538K | -5.11M |
| Equity Growth % | - | 1.19% | 2.73% | -0.23% | -0.96% | -10.51% |
| Book Value per Share | 139.77 | 306.32 | 1365.28 | 834.04 | 32.06 | -241.26 |
| Total Shareholders' Equity | 1.97M | 4.33M | 16.13M | 12.39M | 538K | -5.11M |
| Common Stock | 279 | 279 | 353 | 0 | 0 | 0 |
| Retained Earnings | 932.63K | 3.29M | -2.66M | -12.57M | -24.91M | -33.57M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Cash from Operations | 3.97M | -734.67K | -7.11M | -2.6M | -1.61M | -1.08M |
| Operating CF Margin % | 0.14% | -0.02% | -0.2% | -0.06% | -0.05% | -0.09% |
| Operating CF Growth % | - | -1.19% | -8.68% | 0.63% | 0.38% | 0.33% |
| Net Income | 1.17M | 2.35M | -5.95M | -9.61M | -12.34M | -5.97M |
| Depreciation & Amortization | 776.13K | 803.19K | 1.42M | 3.37M | 7.23M | 889K |
| Stock-Based Compensation | 0 | 0 | 52K | 257K | 17K | 87K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.29M | 0 | 1.31M | -928K | 481K | 1.22M |
| Working Capital Changes | -1.27M | -3.89M | -3.95M | 4.31M | 3M | 2.69M |
| Change in Receivables | 212.99K | -2.23M | -3.65M | 4.08M | 2.27M | 2.12M |
| Change in Inventory | -3.42M | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 3.42M | -750.38K | 0 | -392K | 484K | 0 |
| Cash from Investing | -3.65M | -477.46K | -7.63M | -3.32M | -13K | 0 |
| Capital Expenditures | -3.65M | -477.46K | -3.13M | -3.32M | -13K | 0 |
| CapEx % of Revenue | 0.13% | 0.02% | 0.09% | 0.07% | 0% | - |
| Acquisitions | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 1.64M | 15.11M | 5.49M | 1.52M | -133K |
| Debt Issued (Net) | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - |
| Other Financing | 0 | 0 | 0 | -265K | 0 | 956K |
| Net Change in Cash | - | - | - | - | - | - |
| Free Cash Flow | 318.86K | -734.67K | -10.24M | -5.92M | -1.63M | -1.08M |
| FCF Margin % | 0.01% | -0.02% | -0.29% | -0.13% | -0.05% | -0.09% |
| FCF Growth % | - | -3.3% | -12.94% | 0.42% | 0.73% | 0.33% |
| FCF per Share | 22.57 | -51.99 | -866.56 | -398.51 | -96.82 | -51.00 |
| FCF Conversion (FCF/Net Income) | 3.39x | -0.31x | 1.20x | 0.27x | 0.13x | 0.18x |
| Interest Paid | 0 | 0 | 567K | 212K | 968K | 121K |
| Taxes Paid | 0 | 0 | 24K | 357K | 35K | 12K |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 59.35% | 74.67% | -58.15% | -67.38% | -190.92% | - |
| Return on Invested Capital (ROIC) | 125.17% | 37.71% | -37.39% | -49.95% | -99.66% | -626.78% |
| Gross Margin | 20.35% | 27.4% | 29.83% | 24.62% | 20.41% | 24.71% |
| Net Margin | 4.08% | 7.51% | -16.87% | -20.94% | -37.16% | -51.03% |
| Debt / Equity | - | 0.17x | 0.21x | 0.19x | 8.02x | - |
| Interest Coverage | 31.75x | 14.96x | -9.45x | -49.13x | -11.72x | -3.92x |
| FCF Conversion | 3.39x | -0.31x | 1.20x | 0.27x | 0.13x | 0.18x |
| Revenue Growth | - | 9.06% | 12.54% | 30.1% | -27.64% | -64.77% |
| 2021 | 2022 | |
|---|---|---|
| Software Services | 12.43M | 23.88M |
| Software Services Growth | - | 92.14% |
| Managed Services And Support | 19M | 15.18M |
| Managed Services And Support Growth | - | -20.13% |
| Platform Services | 3.84M | 4.83M |
| Platform Services Growth | - | 25.76% |
Healthcare Triangle, Inc. (HCTI) reported $12.9M in revenue for fiscal year 2024. This represents a 55% decrease from $28.7M in 2019.
Healthcare Triangle, Inc. (HCTI) saw revenue decline by 64.8% over the past year.
Healthcare Triangle, Inc. (HCTI) reported a net loss of $6.3M for fiscal year 2024.
Healthcare Triangle, Inc. (HCTI) had negative free cash flow of $12.3M in fiscal year 2024, likely due to heavy capital investments.